← Evidence map

ArticleTherapeutic advances in medical oncology2022

The economic value of liquid biopsy for genomic profiling in advanced non-small cell lung cancer.

Doreen A Ezeife et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

37 papers cite it

2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 35923926